Treatment of neonatal sepsis with intravenous immune globulin
Research output: Contribution to journal › Journal article › Research › peer-review
Neonatal sepsis is a major cause of death and complications despite antibiotic treatment. Effective adjunctive treatments are needed. Newborn infants are relatively deficient in endogenous immunoglobulin. Meta-analyses of trials of intravenous immune globulin for suspected or proven neonatal sepsis suggest a reduced rate of death from any cause, but the trials have been small and have varied in quality.
Original language | English |
---|---|
Journal | New England Journal of Medicine |
Volume | 365 |
Issue number | 13 |
Pages (from-to) | 1201-11 |
Number of pages | 11 |
ISSN | 0028-4793 |
DOIs | |
Publication status | Published - 2011 |
ID: 40157036